Antifungal Drugs Market Growth Examines by Latest Trends, Factors, and Key Players 2027

Antifungal Drugs Market to 2027 - Global Analysis and Forecasts By Infection Type (Superficial Fungal Infection, Systemic Fungal Infection); Drug Type (Echinocandins, Azoles, Polyenes, Allylamines, Others); Therapeutic Indication (Aspergillosis, Dermatophytosis, Candidiasis, Others); Dosage form (Drugs, Ointment, Powder, Others) and Geography

According to a new market research study titled ‘Antifungal Drugs Market to 2027 – Global Analysis and Forecasts by Infection Type, Drug Type, Therapeutic Indication, Dosage Form and Geography. The global Antifungal Drugs market is expected to reach US$ 13,524.2 Mn in 2027 from US$ 10,182.3 Mn in 2018. The market is estimated to grow with a CAGR of 3.2% from 2019-2027. The report highlights the trends prevalent in the global Antifungal Drugs market and the factors driving the market along with those that act as challenges to its growth.

The market for Antifungal Drugs is expected to grow significantly due to factors such as rising incidences for the fungal infection of the skin, nails and hair, increasing incidences of cancers, HIV, and hospital-acquired infections and favorable government initiatives to combat the antifungal diseases are likely to drive the growth of the Antifungal Drugs market. However, lack of awareness regarding the fungal infections may restrict the growth of Antifungal Drugs market.

Get Sample Copy of the Report at –

Company Profiles Include:

  • Pfizer Inc.
  • Sanofi S.A.
  • Gilead Sciences, Inc.
  • Merck And Co., Inc.
  • Scynexis Inc.
  • Novartis International AG
  • Abbott Laboratories
  • Bayer AG
  • Glenmark Pharmaceutical
  • Glaxosmithkline Plc.

The incidence of fungal infections due to numerous diseases has increased over the last few decades. Furthermore, bloodstream infection incidence is bimodal, with adult people and premature babies having the maximum risk. Cancer treatment using chemotherapy and radiation causes various changes in the body as they destruct cancer cells. Among the significant difference, one is that this treatment weakens the immune system that increases the chances of getting a fungal infection.Many fungal infections are called opportunistic infections, as they generally affect people with weak immune systems. As HIV weakens the immune system, it is more prone to have some types of fungal infections, like coccidioidomycosis, histoplasmosis, cryptococcosis, and pneumocystis pneumonia (PCP).

The developing nations are incredibly diverse, and the diseases and health care problems they face are somewhat variable. Thus, the solutions are different and must be made to fit local circumstances. Emerging nations represent an excellent opportunity for the pharmaceutical industry. The emerging markets are expected to be the crucial factor for offering better and lucrative growth opportunities for the market players to expand their business and geographic reach.The treatment for the fungal infections become more straightforward due to the help of the advancement in the technologies. Also, the healthcare expenditure has created lots of opportunities for the developing nations to provide better and more services and facilities to their people. Regions like Asia, the Middle East, and Africa are investing more in the healthcare sectors.

Strategic Insights

Organic and inorganic growth strategies were observed in global Antifungal Drugs industry. The organic strategies which were conducted more compared to the inorganic strategies for the Antifungal Drugs. For instance, in November, 2017, Merck & Co., Inc. declared that the U.S. Food and Drug Administration (FDA) approved PREVYMIS (letermovir) to be uses as once-daily tablets for oral use and injection for intravenous infusion. Thus, the organic strategy has enabled the company to grow its business in the market.


Global Antifungal Drugs Market – By Infection Type

  • Superficial Fungal Infection
  • Systemic Fungal Infection

Global Antifungal Drugs Market – By Drug Type

  • Echinocandins
  • Azoles
  • Polyenes
  • Allylamines
  • Others

Global Antifungal Drugs Market – By Therapeutic Indication

  • Aspergillosis
  • Dermatophytosis
  • Candidiasis
  • Others

Global Antifungal Drugs Market – By Dosage Form

  • Drugs
  • Ointment
  • Powder
  • Others

Purchase this Report at –

Reasons to Buy the Report:

– Learn about the driving factors, affecting the market growth.

– Imbibe the advancements and progress in the market during the forecast period.

– Understand where the market opportunities lies.

– Compare and evaluate various options affecting the market.

– Pick up on the leading market players within the market.

– Envision the restrictions and restrains that are likely to hamper the market. 

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:

Call: +1-646-491-9876




Related Articles